Stone Summit Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Stone Summit Wealth's LLY Position: Q3 2026 in Review
Stone Summit Wealth reduced its Eli Lilly (LLY) stake by 8.1% in Q3 2026, selling an estimated $330K and leaving 3,190 shares worth $3.69M. The position accounts for 1% of the portfolio, ranked #31.
Stone Summit Wealth first reported a position in LLY in Q1 2022 and has held it in 19 quarters since. The position peaked at $4.16M in Q2 2026. 1,138 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Stone Summit Wealth held 3,190 shares of Eli Lilly worth $3.69M as of Q3 2026.
- Stone Summit Wealth sold 280 Eli Lilly shares in Q3 2026, an estimated $330K.
- Eli Lilly made up 1% of Stone Summit Wealth's portfolio in Q3 2026, its #31 holding.
- Stone Summit Wealth first reported a position in Eli Lilly in Q1 2022 and has held it in 19 quarters since.
- Stone Summit Wealth's Eli Lilly position peaked at $4.16M in Q2 2026.
- 1,138 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Stone Summit Wealth's 13F filing for Q3 2026, filed 14 Oct 2026.